Author

Kaitlyn Bootz

Brigham and Women's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Charles Stiles· 1 shared Christopher J. GraseriD· 1 shared Daphne Adele Haas-KoganiD· 1 shared Dipanjan ChowdhuryiD· 1 shared Franziska Michor AiD· 1 shared Graeme Smith· 1 shared Helen Robinson· 1 shared Heng Wang· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Charles Stiles

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

H3K27M-driven hypertranscription leads to a new targetable dependency in diffuse midline gliomas

Sharmistha Pal, Heng Wang, Jacob Geisberg, Tasmia Mirza, Khushi Kohli, А. Ш. Назаретян, Truman Knowles, Christopher J. Graser, Kaitlyn Bootz, Olga Wójcikowska, Magda Bartyńska, Simon J. Boulton, Jayesh B. Majithiya, Helen Robinson, Graeme Smith, , Daphne Adele Haas-Kogan

This study identifies hypertranscription as a vulnerability in H3K27M-driven diffuse midline gliomas, showing ATR inhibition effectively targets this feature in preclinical models.

bioRxiv · May 15, 2026 · PreprintCancer Biology